Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation AnalysisĮmerging Trends in the Sex Reassignment Surgery Market : Rumer Cosmetic Surgery, Transgender Surgery Institute, Mount Sinai Centre for Transgender Medicine and Surgery (CTMS), Phuket International Aesthetic Centre (PIAC), Chettawut Plastic Surgery Center, Charing Cross Gender Identity Clinic, Sava Perovic Foundation Surgery, Boston Medical Center, Cleveland Clinic, CNY Cosmetic & Reconstructive Surgery and Bupa Cromwell Hospital. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Sex Reassignment Surgery Market Regional Scope Sex Reassignment Surgery Market Forecast Dataīy Gender Transition, By End-Use, And By Geography Sex Reassignment Surgery Market Base Year Sex Reassignment Surgery Market Analysis Period Sex Reassignment Surgery Market CAGR During 2023 - 203 2 Sex Reassignment Surgery Market Forecast 203 2 Sex Reassignment Surgery Market Size 202 2 This growth is anticipated due to the continued rise in the recognition of transgender rights, improvements in healthcare policies, and advancements in medical technology. These include the high cost of these surgeries, which can often make them inaccessible to many, and a significant shortage of skilled surgeons specializing in these procedures.ĭespite these challenges, the market for sex reassignment surgeries is expected to continue to grow in the years to come. However, there are considerable challenges that could potentially impact the rise of the sex reassignment surgery market. Better healthcare policies are now being implemented in various regions worldwide, which cover the costs of such surgeries and make them more accessible to those who need them. Furthermore, there have been significant advancements in the surgical procedures themselves, making them more efficient and safer, thereby increasing their demand. Societal acceptance of transgender individuals has been growing, and this has led to a rise in the number of people who identify as transgender and wish to undergo such surgeries. The market for these surgeries is fueled by several factors. These surgeries play a crucial role in the transition process for many transgender individuals. Sex reassignment surgeries are intricate surgical procedures that change the physical appearance and functionality of an individual's existing sexual characteristics to mirror those of their identified gender.
LOS ANGELES, J(GLOBE NEWSWIRE) - The Global Sex Reassignment Surgery Market Size accounted for USD 519.8 Million in 2022 and is estimated to achieve a market size of USD 3,171.3 Million by 2032 growing at a CAGR of 20.4% from 2023 to 2032.Īn In-depth Understanding of the Sex Reassignment Surgery Market : To read this article on click here.Acumen Research and Consulting recently published report titled “Sex Reassignment Surgery Market Forecast, 2023 - 2032”
#SAVA YAHOO FINANCE FREE#
Click to get this free reportĬassava Sciences, Inc.
#SAVA YAHOO FINANCE DOWNLOAD#
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. You can find more information on all of these metrics, and much more, on. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. This group has a Zacks Industry Rank of 151, putting it in the bottom 41% of all 250+ industries. The Medical - Drugs industry is part of the Medical sector. is holding a Zacks Rank of #3 (Hold) right now. Within the past 30 days, our consensus EPS projection has moved 37.14% higher. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. Research indicates that these estimate revisions are directly correlated with near-term share price momentum.
As such, positive estimate revisions reflect analyst optimism about the company's business and profitability. These revisions help to show the ever-changing nature of near-term business trends. Any recent changes to analyst estimates for Cassava Sciences, Inc.
0 kommentar(er)
